NSAID-induced polyp regression in familial adenomatous polyposis patients

被引：41
|
作者：
Giardiello, FM
机构：
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,HEREDITARY COLORECTAL CANC CLIN & REGISTRY,BALTIMORE,MD
来源：
GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 1996年 / 25卷 / 02期
关键词：
D O I：
10.1016/S0889-8553(05)70251-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
NSAIDs inhibit prostaglandin synthesis. In 1983, Waddell et al first reported that sulindac, a NSAID (Clinoril), caused regression of rectal adenomatous polyps in several patients with familial adenomatous polyposis, an inherited form of colorectal cancer. Subsequently, NSAIDs have been used as chemopreventive agents in animal carcinogenesis models and adenoma regression has been confirmed in human trials with sulindac. This article summarizes these developments and describes possible mechanisms of colorectal neoplasia chemoprevention.
引用
收藏
页码：349 / &
页数：14
相关论文
共 50 条
  • [1] Oral contraceptives and polyp regression in familial adenomatous polyposis
    Giardiello, FM
    Hylind, LM
    Trimbath, JD
    Hamilton, SR
    Romans, KE
    Cruz-Correa, M
    Corretti, MC
    Offerhaus, GJA
    Yang, VW
    GASTROENTEROLOGY, 2005, 128 (04) : 1077 - 1080
  • [2] Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis
    Stoner, GD
    Budd, GT
    Ganapathi, R
    DeYoung, B
    Kresty, LA
    Nitert, M
    Fryer, B
    Church, JM
    Provencher, K
    Pamukcu, R
    Piazza, G
    Hawk, E
    Kelloff, G
    Elson, P
    van Stolk, RU
    COLON CANCER PREVENTION: DIETARY MODULATION OF CELLULAR AND MOLECULAR MECHANISMS, 1999, 470 : 45 - 53
  • [3] Black raspberry-mediated metabolic changes in patients with familial adenomatous polyposis associated with rectal polyp regression
    Huang, Yi-Wen
    Chen, Hui-zhi
    Niu, Ben
    Wu, Weijie
    Gao, Haiyan
    Yu, Jianhua
    Wang, Li-Shu
    FOOD FRONTIERS, 2024, 5 (02): : 259 - 266
  • [4] Utility of Mesalazine in Familial Adenomatous Polyposis: Clinical Report of Reduction of Polyp Size in Patients with Ulcerative Colitis, and Safety Examination in Familial Adenomatous Polyposis Patients
    Ishikawa, Hideki
    Mutoh, Michihiro
    Abe, Takashi
    Nakajima, Takeshi
    Takeuchi, Yoji
    Ezoe, Yasumasa
    Wakabayashi, Keiji
    Doyama, Hisashi
    Sakai, Toshiyuki
    PHARMACOLOGY, 2019, 104 (1-2) : 51 - 56
  • [5] Colorectal polyp counts and cancer risk in familial adenomatous polyposis
    Debinski, HS
    Love, S
    Spigelman, AD
    Phillips, RKS
    GASTROENTEROLOGY, 1996, 110 (04) : 1028 - 1030
  • [6] Fundic gland polyp dysplasia is common in familial adenomatous polyposis
    Bianchi, Laura K.
    Bennett, Ana E.
    Lopez, Rocio
    Hasson, Hennie
    Burke, Carol A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S159 - S159
  • [7] Significance of fondle gland polyp carpeting in familial adenomatous polyposis
    Silverberg, MS
    Berk, T
    Riddell, R
    Gallinger, S
    GASTROENTEROLOGY, 2003, 124 (04) : A549 - A549
  • [8] Giant fundic polyp complicating attenuated familial adenomatous polyposis
    McGarrity, TJ
    Ruggiero, FM
    Chey, WY
    Bajaj, R
    Kelly, JE
    Kauffman, GL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07): : 1824 - 1828
  • [9] Fundic gland polyp dysplasia is common in familial adenomatous polyposis
    Bianchi, Laura K.
    Bennett, Ana
    Lopez, Rocio
    Hennie, Hasson
    Laguardia, Lisa
    Church, James
    Burke, Carol A.
    GASTROENTEROLOGY, 2007, 132 (04) : A617 - A617
  • [10] Fundic gland polyp dysplasia is common in familial adenomatous polyposis
    Bianchi, Laura K.
    Burke, Carol A.
    Bennett, Ana E.
    Lopez, Rocio
    Hasson, Hennie
    Church, James M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (02) : 180 - 185
12345